GILEAD 701 (Truvada 200 mg / 300 mg)
Generic Name: emtricitabine/tenofovir
Pill imprint GILEAD 701 has been identified as Truvada 200 mg / 300 mg.
Truvada is used in the treatment of pre-exposure prophylaxis; hiv infection; nonoccupational exposure and belongs to the drug class antiviral combinations. There is no proven risk in humans during pregnancy. Truvada 200 mg / 300 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for GILEAD 701 (Truvada 200 mg / 300 mg)
- Generic Name:
- 200 mg / 300 mg
- 19.00 mm
- Prescription only
- Drug Class:
- Antiviral combinations
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Gilead Sciences
- National Drug Code (NDC):
- Inactive Ingredients:
- croscarmellose sodium
FD&C Blue No. 2
|NDC Code||Manufacturer / Repackager|
|54569-5588||A S Medication Solutions LLC (repackager)|
|54868-5141||Physicians Total Care Inc (repackager)|
|55045-3481||Dispensing Solutions Inc. (repackager)|
|35356-0070||Lake Erie Medical and Surgical Supply (repackager)|
|52959-0969||H.J. Harkins Company, Inc (repackager)|
Note: Inactive ingredients may vary.
More about Truvada (emtricitabine / tenofovir)
- Other brands: AccessPak for HIV PEP Basic